PCP
AMED

Perbak Capital Partners’s Amedisys AMED Stock Holding History

Perbak Capital Partners’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,523
Closed -$248K – 296
2025
Q2 		$248K Buy
+2,523
New +$239K 0.06% 256

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Perbak Capital Partners's AMED Position: Q3 2025 in Review

Perbak Capital Partners sold out of Amedisys (AMED) in Q3 2025, closing a stake of 2,523 shares — an estimated $248K sold.

Perbak Capital Partners first reported a position in AMED in Q2 2025 and held it in 1 quarter. The position peaked at $248K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Perbak Capital Partners reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Perbak Capital Partners sold 2,523 Amedisys shares in Q3 2025, an estimated $248K.
  • Perbak Capital Partners first reported a position in Amedisys in Q2 2025 and held it in 1 quarter.
  • Perbak Capital Partners's Amedisys position peaked at $248K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Perbak Capital Partners's 13F filing for Q3 2025, filed 13 Nov 2025.